Since Pyrin can detect perturbations in Rho-GTPases [537], further investigations into whether Pyrin can detect Rho-GTPase alterations in cancers and neurological conditions, where Rho-GTPase dysregulation is frequently observed [562–564], could enhance our understanding of Pyrin and guide the development of targeted interventions. Here, MEFV is linked to cancer.